Youtube logo 

Disfruta de los vídeos de nuestro canal de Youtube

Donaciones

Acceso

  1. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I. Myasthenia gravis: A higher than expected incidence in the elderly.Neurology. 2003 Mar 25;60(6):1024-6.
  2. Barth D, Nabavi Nouri M, Ng E, Nwe P, Bril V. Comparison of IVIg and PLEX in patients with myasthenia gravis.Neurology. 2011 Jun 7;76(23):2017-23
  3. Benatar M, Sanders DB, Burns TM, Cutter GR, Guptill JT, Baggi F, Kaminski HJ, Mantegazza R, Meriggioli MN, Quan J, Wolfe GI; THE TASK FORCE ON MG STUDY DESIGN OF THE MEDICAL SCIENTIFIC ADVISORY BOARD OF THE MYASTHENIA GRAVIS FOUNDATION OF AMERICA. Muscle Nerve. 2012 Recommendations for myasthenia gravis clinical trials.Jun;45(6):909-917.
  4. Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest 2006;116(11):2843-54
  5. Diaz-Manera J, Rojas-Garcia R, Illa I Treatment strategies for myasthenia gravis Expert Opin. Pharmacother. (2009) 10(8):1329-1342
  6. Díaz-Manera J, Martínez-Hernández E, Querol L, Klooster R, RojasGarcía R, Suárez-Calvet X, Muñoz-Blanco JL, Mazia C, Straasheijm KR, Gallardo E, Juárez C, Verschuuren JJ, Illa I. Long-lasting treatment effect of rituximab in MuSK myasthenia.Neurology. 2012 Jan 17;78(3):189-93
  7. Guptill JT, Sanders DB. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. Curr Opin Neurol 2010;23:530 – 535.
  8. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 2000;55:16-23
  9. Meriggioli MN, Sanders DB.Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009 May;8(5):475- 90.
  10. Newsom-Davis J. Therapy in myasthenia gravis and Lambert-Eaton Myasthenic syndrome. Semin Neurol 2003;23:191-8
  11. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW; European Federation of Neurological Societies.Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2010 Jul;17(7):893- 902